Display options
Cite
Messripour M, Mesripour A, Mashayekhie FJ. The effects of increasing PGE2 on translocation of labeled albumin into rat brain. Res Pharm Sci. 2015;10(2):177-81
Messripour, M., Mesripour, A., & Mashayekhie, F. J. (2015). The effects of increasing PGE2 on translocation of labeled albumin into rat brain. Research in pharmaceutical sciences, 10(2), 177-81.
Messripour, M, et al. "The effects of increasing PGE2 on translocation of labeled albumin into rat brain." Research in pharmaceutical sciences vol. 10,2 (2015): 177-81.
Messripour M, Mesripour A, Mashayekhie FJ. The effects of increasing PGE2 on translocation of labeled albumin into rat brain. Res Pharm Sci. 2015 Mar-Apr;10(2):177-81. PMID: 26487895; PMCID: PMC4584457.
Copy Download .nbib Format: NLM
Share it on

Res Pharm Sci. 2015 Mar-Apr;10(2):177-81.

The effects of increasing PGE2 on translocation of labeled albumin into rat brain.

Research in pharmaceutical sciences

M Messripour, A Mesripour, F J Mashayekhie

Affiliations

  1. Department of Medical Biochemistry, Khorasgan Branch, Islamic Azad University, Isfahan, I.R. Iran.
  2. Medical Plant Research Center, Shahre Kord University of Medical Sciences, Shahre Kord, I.R. Iran.
  3. School of Paramedical Sciences, Arak University of Medical Sciences, Arak, I.R. Iran.

PMID: 26487895 PMCID: PMC4584457

Abstract

Under pathophysiological conditions, infiltration of leukocyte plays a key role in the progression of the neuroinflammatory reaction in the CNS. Prostaglandin E2 (PGE2) is known to accumulate at lesion sites of the post-ischemic brain. Although post-ischemic treatments with cyclooxygenase-2 inhibitors reduce blood-brain barrier (BBB) leukocyte infiltration, the direct effect of PGE2 on BBB has not been fully implemented. Therefore, the direct effect of increasing PGE2 infusion on translocation of labeled albumin into the brain was assessed. Under anesthesia rats were drilled stereo-taxicaly a burr hole in the right forebrain and PGE2 was infused into the forebrain and the hole was occluded. The animals were then injected with fluorescent labeled albumin (FA), via internal right jugular vein and decapitated at different infusion time points. The forebrain was removed and each forebrain hemisphere was homogenized and fluorescence intensities were measured in the supernatant. The fluorescence intensities measured in the right and left forebrain hemispheres of the control group (0.0 μg PGE2) were almost identical. Four hours after infusion of PGE2 at doses higher than 250 μg, fluorescence intensity increased in the right forebrain supernatant, even if it was not statistically significant. The fluorescence intensity was detectable in the brain supernatant 4 h after infusion of PGE2 in doses higher than 250 μg PGE2. The highest fluorescence intensity was 16 h after infusion of 500 μg PGE2, which returned to near control values after 48 h. Increased fluorescence intensity in the brain following PGE2 infusion is concluded to be associated with disruption of the BBB.

Keywords: Blood-brain barrier; Ischemia; Neuroinflammatory; Prostaglandin

References

  1. J Cereb Blood Flow Metab. 2001 Dec;21(12):1436-41 - PubMed
  2. J Neurosci. 2004 Jan 7;24(1):257-68 - PubMed
  3. J Cell Physiol. 2006 Jan;206(1):68-77 - PubMed
  4. J Neurotrauma. 2000 Aug;17(8):695-711 - PubMed
  5. Stroke. 2006 May;37(5):1288-95 - PubMed
  6. Brain Res. 2004 May 8;1007(1-2):98-108 - PubMed
  7. Cell Mol Neurobiol. 2000 Apr;20(2):131-47 - PubMed
  8. J Neurochem. 2005 Jun;93(6):1561-7 - PubMed
  9. Clin Chim Acta. 1978 Nov 1;89(3):461-7 - PubMed
  10. Nat Med. 2006 Feb;12(2):225-9 - PubMed
  11. Trends Neurosci. 1999 Sep;22(9):391-7 - PubMed
  12. Ernst Schering Res Found Workshop. 2004;(47):87-99 - PubMed
  13. Exp Neurol. 2003 Dec;184(2):973-80 - PubMed
  14. J Neuroinflammation. 2005 Jan 18;2(1):3 - PubMed
  15. Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1925-31 - PubMed
  16. J Cereb Blood Flow Metab. 2000 May;20(5):812-9 - PubMed
  17. J Biol Chem. 2006 Feb 10;281(6):3321-8 - PubMed
  18. J Cereb Blood Flow Metab. 1999 Aug;19(8):819-34 - PubMed
  19. Int J Clin Pract. 2006 Apr;60(4):399-407 - PubMed
  20. J Cereb Blood Flow Metab. 2004 Jan;24(1):107-13 - PubMed
  21. Neurosci Lett. 2002 Sep 13;330(1):57-60 - PubMed
  22. Brain Pathol. 2000 Jan;10(1):113-26 - PubMed
  23. Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11790-5 - PubMed
  24. J Biol Chem. 2004 May 21;279(21):22039-46 - PubMed

Publication Types